Cite
APA Citation
Mease, P. J., Smolen, J. S., Kavanaugh, A., Nash, P., Gallo, G., Liu Leage, S., Sapin, C., & Genovese, M. C. (n.d.). aB0802 SAFETY PROFILES OF IXEKIZUMAB VERSUS ADALIMUMAB: 52-WEEK RESULTS FROM A HEAD-TO-HEAD COMPARISON IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS. Annals of the rheumatic diseases, 79, 1701–1702. http://access.bl.uk/ark:/81055/vdc_100144717227.0x000040